Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion type Assertion NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_head.
- NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion description "[However, while EphA2 has been reported to enhance tumorigenesis, proliferation, and MAPK activation in several model systems, other studies suggest that EphA2 activation diminishes these processes and inhibits the activity of MAPK upon ligand stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_provenance.
- NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion evidence source_evidence_literature NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_provenance.
- NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion SIO_000772 18079969 NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_provenance.
- NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion wasDerivedFrom befree-2016 NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_provenance.
- NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_assertion wasGeneratedBy ECO_0000203 NP645255.RApQEexExObXXdVfm3wTmRXd6UjfNeIG6AYVsh2uaef6E130_provenance.